The antibacterial paradox: essential drugs, effectiveness, and cost.
The concept proposed by WHO of an essential drugs list that should comprise drugs corresponding to the health needs of the majority of the people has been embraced by countries, which have adapted it to their needs. In this study, the essential antibacterial drug lists of 16 countries chosen from the six WHO regions are reviewed. Most of these countries include 73% of WHO-recommended essential antibacterials on their lists. However, most are lacking reserve antibacterials, and even some main list antibacterials, which are essential when empirical therapy fails in cases of bacterial resistance. Many factors that may be responsible for the lack of selection of these drugs, not least cost considerations, are discussed.
Fasehun
F
F
World Health Organization, Geneva, Switzerland.
D000328:Adult; D000890:Anti-Infective Agents / Q000191:economics* / Q000627:therapeutic use*; D016527:Drug Costs; D004352:Drug Resistance, Microbial; D017723:Drug Utilization Review; D018954:Drugs, Essential; D014943:Global Health; D006291:Health Policy; D006801:Humans
D000890:Anti-Infective Agents; D018954:Drugs, Essential